A randomized trial assessing the efficacy, immunogenicity, and safety of vaccination with live attenuated varicella zoster virus-containing vaccines: ten-year follow-up in Russian children

• Main Authors: Leyla Namazova-Baranova (Author), Md Ahsan Habib (Author), Michael Povey (Author), Kamilla Efendieva (Author), Olga Fedorova (Author), Marina Fedoseenko (Author), Tatyana Ivleva (Author), Yulia Kovshirina (Author), Julia Levina (Author), Artem Lyamin (Author), Ludmila Ogorodova (Author), Olga Reshetko (Author), Viktor Romanenko (Author), Inna Ryzhenkova (Author), Irina Sidorenko (Author), Yakov Yakovlev (Author), Aleksandr Zhestkov (Author), Vladimir Tatochenko (Author), Michael Scherbakov (Author), Evgeniy L Shpeer (Author), Giacomo Casabona (Author), on behalf of the OKAH-182 Russia Study Group (Author)
• Format: Book
• Published: Taylor & Francis Group, 2022-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

In Russia, a universal varicella vaccination (UVV) program has not been implemented, and varicella vaccination coverage is low. We assessed the efficacy, antibody persistence, and safety of one- and two-dose varicella vaccination schedules in Russian children with a ten-year follow-up period, as par...